US prescriptions for Novo Nordisk's (NOVOB DC) Wegovy pill were 3,071 for the first four days of launch, via IQVIA data

The initial prescription numbers for Novo Nordisk's Wegovy pill indicate a promising market reception, with over 3,000 prescriptions in just the first four days.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

US BROKER MOVES: STX upgraded at Susquehanna; HPQ downgraded at Barclays

State Street Corporation (STT) Q4 2025 (USD): Adj. 2.97 (exp. 2.79), Revenue 3.667bln (exp. 3.60bln), NII 802mln (exp. 762.9mln)

US prescriptions for Novo Nordisk's (NOVOB DC) Wegovy pill were 3,071 for the first four days of launch, via IQVIA data

US PRE-MARKET MOVERS: INTC, JBHT, RF, PNC, ASTS

Ukrainian President Zelensky says Ukrainian delegation heading to US for talks on security guarantees and prosperity package; if agreement is reached, documents can be signed in Davos

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This strong start could potentially bolster investor sentiment around the stock and suggest robust demand dynamics, impacting both supply and pricing strategies moving forward. Traders should watch for how this performance aligns with market expectations and compares with peers in the sector.

Related headlines

The whole workspace, free to try.

Try it free